Expression and clinical significance of erb-B receptor family in hepatocellular carcinoma

British Journal of Cancer

Volumn 84, Issue 10, 2001, Pages 1377-1383

  Ito, Y ^a,b   Takeda, T ^a   Sakon, M ^b   Tsujimoto, M ^c   Higashiyama, S ^d   Noda, K ^d   Miyoshi, E ^d   Monden, M ^b   Matsuura, N ^b  

^a Department of Surgery   (Japan)

^b Department of Pathology ^*

^c OSAKA POLICE HOSPITAL   (Japan)

^d OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

C erbB 2; C erbB 3; C erbB 4; EGF R; Hepatocellular carcinoma; Immunohistochemistry

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CELL PROLIFERATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MALE; METASTASIS; MULTIGENE FAMILY; ONCOGENE C ERB; PRIORITY JOURNAL; PROGNOSIS; TUMOR VOLUME;

CARCINOMA, HEPATOCELLULAR; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RECEPTOR, ERBB-3; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 0035906821     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2000.1580     Document Type: Article

References (52)

1. Type 1 receptor tyrosine kinases are differentially phosphorylated in mammary carcinoma and differentially associated with steroid receptors
2. Al Erb B receptors other than the epidermal growth factor receptor are endocytosis impaired
3. Hepatocellular carcinoma and hepatitis B virus
4. Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer
5. c-erbB-3 protein expression in ductal carcinoma in situ of the breast
6. Clinical and prognostic significance of the expression of the c-erbB-2 and c-erbB-3 oncoproteins in primary and metastatic malignant melanomas and breast carcinomas
7. HER-2/neu amplification predicts poor survival in node-positive breast cancer
8. Immunoreactivity for c-erbB-2 oncopeptide in benign and malignant diseases of the liver
9. Oncogenes and signal transduction
10. Ligand-induced internalization of the epidermal growth factor receptor is mediated by multiple endocytic codes analogous to the tyrosine motif found in constitutively internalized receptors
11. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction
12. Expression patterns of erbB receptor family in normal urothelium and transitional cell carcinoma
13. c-erbB-2 oncogene expression in hepatocellular carcinoma and cholangiocarcinoma
14. HER-2/neu expression in pancreatic adenocarcinoma: Relation to tumor differentiation and survival
15. Activation or HER4 by heparin binding EGF-like growth factor stimulates chemotaxis but not proliferation
16. Concomitant analysis of the epidermal growth factor receptor family in esophageal cancer: Overexpression of epidermal growth factor receptor mRNA but not of c-erbB-2 and c-erbB-3
17. Expression of c-erbB-3 and c-erbB-4 proteins in papillary thyroid carcinomas
18. Cell proliferation, apoptosis, oncogene, and tumor suppressor gene status in adenosis with comparison to benign prostatic hyperplasia, prostatic intraepithelial neoplasia, and cancer
19. Expression of c-erbB proto-oncogene family members in squamous cell carcinoma of the head and neck
20. Both cell proliferation and apoptosis significantly predict shortened disease-free survival in hepatocellular carcinoma
21. Expression and clinical significance of the erbB family in intrahepatic cholangiocellular carcinoma
22. Expression of ERBB2 in human gastric carcinomas: Relationship between p185ERBB2 expression and the gene amplification
23. Expression of erbB-3 protein in colorectal adenocarcinoma: Correlation with poor survival
24. p185neu expression in human lung adenocarcinomas predicts shortened survival
25. c-erbB-4 protein expression in human breast cancer
26. Epidermal growth factor-dependent association of phosphatidylinositol 3-kinase with the erbB3 gene product
27. Expression of transforming growth factor alpha and epidermal growth factor receptor in human hepatocellular carcinoma
28. Epiregulin binds to epidermal growh factor receptor and ErbB-4 and induces tyrosine phosphorylation of epidermal growth factor receptor, ErbB-2, ErbB-3 and ErbB-4
29. Isolation and characterisation of c-erbB-3, a third member of the erbB/epidermal growth factor receptor family; evidence of over expression in a subset of human mammary tumours
30. Epidermal growth factor receptor immunoreactivity in gallbladder and extrahepatic biliary tract tumours
31. C-erb-B-2 oncoprotein and epidermal growth factor receptor in human hepatocellular carcinoma: An immunohistochemical study
32. Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions
33. Ligand-specific activation of HER4/p180, a fourth member of the epidermal growth factor receptor family
34. Betacellulin activates the epidermal growth factor receptor and erbB-4, and induces cellular response patterns distinct from those stimulated by epidermal growth factor or neuregulin
35. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma
36. Expression of the c-erbB-3 gene product in gastric cancer
37. The cell cycle associated change of the Ki-67 reactive nuclear antigen expression
38. Expression of c-erbB family gene products in adenoid cystic carcinoma of salivary glands: An immunohistochemical study
39. c-erbB growth-factor-receptor proteins in ovarian tumours
40. ErbB3 is involved in activation of phosphaidylinositol 3-kinase by epidermal growth factor
41. Expression of the c-erbB-4/HER-4 protein and mRNA in normal human fetal and adult tissues and in a survey of the nine solid tumour types
42. Expression of the c-erbB-3/HER-3 and c-erbB-4/HER-4 growth factor receptors and their ligands, neuregulin-1 α, neuregulin-1 β, and betacellulin, in normal endometrium and endometrial cancer
43. Nuclear expression of the c-erbB-4/HER-4 growth factor receptor in invasive breast cancers
44. Type 1 protein tyrosine kinases in benign and malignant breast lesions
45. c-erbB-2 protein is expressed in hepatolithiasis and cholangiocarcinoma
46. C-erbB-3 in human breast carcinoma: Expression and relation to prognosis and established prognostic indicators
47. Signal transduction by receptors with tyrosine kinase activity
48. Liver carcinogenesis in tropical Africa
49. Overexpression of c-erbB-2 mRNA and/or c-neu oncoprotein is a predictor for metastases from colorectal cancer
50. Neuregulin-3 (NRG3): A novel neural tissue-enriched protein that binds and activates ErbB4